MannKind Corp
NASDAQ:MNKD

Watchlist Manager
MannKind Corp Logo
MannKind Corp
NASDAQ:MNKD
Watchlist
Price: 5.94 USD 2.24% Market Closed
Market Cap: 1.8B USD

Relative Value

The Relative Value of one MNKD stock under the Base Case scenario is hidden USD. Compared to the current market price of 5.94 USD, MannKind Corp is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MNKD Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
73
vs Industry
58
Median 3Y
6.1
Median 5Y
7.9
Industry
7.9
Forward
5.3
vs History
17
vs Industry
3
Median 3Y
42.6
Median 5Y
-11.7
Industry
23.7
Forward
74.7
vs History
23
vs Industry
5
Median 3Y
34.1
Median 5Y
-11.8
Industry
22
vs History
4
vs Industry
9
Median 3Y
-12.9
Median 5Y
-10.5
Industry
23.8
vs History
vs Industry
Median 3Y
-5.6
Median 5Y
-5.4
Industry
3.3
vs History
79
vs Industry
47
Median 3Y
7
Median 5Y
9.2
Industry
8.3
Forward
5.5
vs History
84
vs Industry
47
Median 3Y
9.8
Median 5Y
15.4
Industry
10.1
vs History
23
vs Industry
7
Median 3Y
17.8
Median 5Y
-16
Industry
6.4
vs History
23
vs Industry
7
Median 3Y
19.6
Median 5Y
-15
Industry
7
Forward
24.3
vs History
26
vs Industry
4
Median 3Y
36.3
Median 5Y
-14.6
Industry
8.3
vs History
26
vs Industry
2
Median 3Y
41.2
Median 5Y
-15.3
Industry
6.5
vs History
69
vs Industry
21
Median 3Y
8.6
Median 5Y
9.4
Industry
5.7

Multiples Across Competitors

MNKD Competitors Multiples
MannKind Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
MannKind Corp
NASDAQ:MNKD
1.8B USD 5.8 63.4 20.1 22.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 790 068.7 -160 599.2 -195 018.6 -192 793.2
US
Abbvie Inc
NYSE:ABBV
394.7B USD 6.6 168.1 16.3 23.1
US
Amgen Inc
NASDAQ:AMGN
170.9B USD 4.8 24.4 17.7 17.7
US
Gilead Sciences Inc
NASDAQ:GILD
149.5B USD 5.1 18.4 12.4 12.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
114.8B USD 9.8 31.2 22.9 23.9
US
Epizyme Inc
F:EPE
94.1B EUR 2 084.9 -532 -579.3 -563.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.1B USD 5.5 17.1 16.2 18.4
AU
CSL Ltd
ASX:CSL
89.1B AUD 3.8 19.7 13.2 16.5
NL
argenx SE
XBRU:ARGX
45.9B EUR 15 35.2 60.9 62.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.4B USD 16.3 1 202.7 158 191.6
P/E Multiple
Earnings Growth PEG
US
MannKind Corp
NASDAQ:MNKD
Average P/E: 175.6
63.4
30%
2.1
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 599.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
168.1
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
24.4
45%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
18.4
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.2
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -532 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.1
9%
1.9
AU
CSL Ltd
ASX:CSL
19.7
11%
1.8
NL
argenx SE
XBRU:ARGX
35.2
40%
0.9
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 202.7
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
MannKind Corp
NASDAQ:MNKD
Average EV/EBITDA: 37.5
20.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 018.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.3
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
17.7
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.4
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.9
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -579.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
11%
1.5
AU
CSL Ltd
ASX:CSL
13.2
8%
1.7
NL
argenx SE
XBRU:ARGX
60.9
839%
0.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
158
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
MannKind Corp
NASDAQ:MNKD
Average EV/EBIT: 43.1
22.1
14%
1.6
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 793.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.1
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
17.7
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.4
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.9
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -563.9 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.4
13%
1.4
AU
CSL Ltd
ASX:CSL
16.5
11%
1.5
NL
argenx SE
XBRU:ARGX
62.6
N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
191.6
N/A N/A